Theragen Etex Coltd Stock Cash Per Share

066700 Stock  KRW 3,205  70.00  2.23%   
Theragen Etex CoLtd fundamentals help investors to digest information that contributes to Theragen Etex's financial success or failures. It also enables traders to predict the movement of Theragen Stock. The fundamental analysis module provides a way to measure Theragen Etex's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Theragen Etex stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Theragen Etex CoLtd Company Cash Per Share Analysis

Theragen Etex's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Cash Per Share

 = 

Total Cash

Average Shares

More About Cash Per Share | All Equity Analysis

Current Theragen Etex Cash Per Share

    
  380.87 X  
Most of Theragen Etex's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Theragen Etex CoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Competition

In accordance with the recently published financial statements, Theragen Etex CoLtd has a Cash Per Share of 380 times. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The cash per share for all Republic of Korea stocks is notably lower than that of the firm.

Did you try this?

Run Companies Directory Now

   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module

Theragen Fundamentals

About Theragen Etex Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Theragen Etex CoLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theragen Etex using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theragen Etex CoLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Theragen Etex

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Theragen Etex position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theragen Etex will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Theragen Etex could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Theragen Etex when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Theragen Etex - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Theragen Etex CoLtd to buy it.
The correlation of Theragen Etex is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Theragen Etex moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Theragen Etex CoLtd moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Theragen Etex can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Theragen Stock

Theragen Etex financial ratios help investors to determine whether Theragen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Theragen with respect to the benefits of owning Theragen Etex security.